Exclusive Journals Coverage

Exclusive Journals Coverage articles provide quick insight and additional author perspectives on select studies recently published in Journal of Clinical Oncology and Journal of Oncology Practice.

Jun 30, 2021
Although progress has been made in the United States over the past 20 years to lower cancer incidence and mortality, Black Americans have the highest death rate and shortest survival of any racial and ethnic group in the U.S. for most cancers.
Jun 23, 2021
In a recently published special article in JCO Global Oncology, the authors present City Cancer Challenge’s (C/Can) framework for strengthening cancer care in cities in low- and middle-income countries and explain how it is implemented.
Nov 16, 2020
In a special two-part series of articles published in JCO Global Oncology (JCO GO), experts take a closer look at oncology care and research in Africa. 
Jun 03, 2020
As oncologists evaluate early research on on COVID-19 and cancer care, Dr. Stephen A. Cannistra notes, the data and conclusions should be interpreted with caution at this stage.
Mar 10, 2020
Dr. Debra Patt shares how JCO Clinical Cancer Informatics (JCO CCI) is using technology to advance health care. 
Sep 07, 2018
Digital health technologies can foster collaboration between physicians, caregivers, and patients by streamlining communication through interactive decision aids, mobile apps, and web-based resources.
Jun 19, 2018
"The State of Oncology Practice in America, 2018" reports on important trends in oncology practice ownership, practice concerns, and the oncology workforce, among other topics.
Feb 26, 2018
Dr. Overman shares an additional perspective on the updated results from CheckMate-142 with ASCO Connection, results which were presented at the 2018 GI Cancers Symposium and simultaneously published online in the Journal of Clinical Oncology (JCO).
Apr 26, 2017
At a time when more people are surviving cancer than ever before, new paradigms of care and perhaps even new definitions of survivorship are needed, according to a paper published in the Journal of Clinical Oncology.
Jan 06, 2017
A study of 30,903 men newly-diagnosed with non-metastatic prostate cancer between 1988 and 2015 found that use of androgen deprivation therapy (ADT), which inhibits cancer growth by lowering testosterone, was not associated with an increased risk of dementia.

Pages